publicationMetadata:
  pmid: "PMID:34011935"
  title: "Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine."
  queryType: "unknown"
  publicationType: "Lab Research"
  publicationTypeConfidence: 0.95
  hasMethodsSection: Yes
  likelyContainsTools: Yes
  expectedToolTypes: |
    Lab Research → antibodies, cell lines, animal models, genetic reagents, computational tools, organoids, PDX
    This is a molecular/cellular biology study investigating MMP1 regulation in NF1 fibroblasts using various
    pharmacological treatments. Expected tools include antibodies for western blotting, primary cell cultures,
    chemical reagents, and potentially computational tools for data analysis.
  overallAssessment: |
    This is a laboratory research study with extensive experimental methods including cell culture, western blotting,
    qRT-PCR, ELISA, and immunohistochemistry. The publication has a comprehensive Methods section describing
    experimental procedures and would be expected to contain multiple research tools including antibodies, cell
    lines, and chemical reagents.

toolValidations: []

potentiallyMissedTools:
  - toolName: "primary dermal fibroblast cells"
    toolType: "cell_line"
    foundIn: "methods"
    contextSnippet: "dermal fibroblast cells were isolated from biopsied skin tissue and cultured as described previously"
    whyMissed: "Primary cell cultures are research tools but may not match standard cell line naming patterns"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "NF1 siRNA (s221793)"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Small interfering RNA (siRNA) targeting NF1 (s221793) or AHR (s1200) and scrambled RNA (Silence Negative Control No. 1) were purchased from Thermo Fisher Scientific"
    whyMissed: "Specific siRNA with catalog number - clear genetic reagent tool"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "AHR siRNA (s1200)"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Small interfering RNA (siRNA) targeting NF1 (s221793) or AHR (s1200) and scrambled RNA (Silence Negative Control No. 1) were purchased from Thermo Fisher Scientific"
    whyMissed: "Specific siRNA with catalog number - clear genetic reagent tool"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "Silence Negative Control No. 1"
    toolType: "genetic_reagent"
    foundIn: "methods"
    contextSnippet: "Small interfering RNA (siRNA) targeting NF1 (s221793) or AHR (s1200) and scrambled RNA (Silence Negative Control No. 1) were purchased from Thermo Fisher Scientific"
    whyMissed: "Control siRNA reagent with specific product name"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "anti-NF1 antibody (#D7R7D)"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "Antibodies used in western blotting targeting β-actin (#13E5), MEK1/2, Akt, c-Raf, ERK, phospho-MEK1/2 (#41G9), phospho-Akt (#D9E), phospho-c-Raf (#56A6), phospho-ERK (#D13.14.4E), MMP1 (#E9S9N), and NF1 (#D7R7D)"
    whyMissed: "Specific antibody with clone number - clear research tool"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "anti-MMP1 antibody (#E9S9N)"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "Antibodies used in western blotting targeting β-actin (#13E5), MEK1/2, Akt, c-Raf, ERK, phospho-MEK1/2 (#41G9), phospho-Akt (#D9E), phospho-c-Raf (#56A6), phospho-ERK (#D13.14.4E), MMP1 (#E9S9N), and NF1 (#D7R7D)"
    whyMissed: "Specific antibody with clone number - clear research tool"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "anti-β-actin antibody (#13E5)"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "Antibodies used in western blotting targeting β-actin (#13E5), MEK1/2, Akt, c-Raf, ERK, phospho-MEK1/2 (#41G9), phospho-Akt (#D9E), phospho-c-Raf (#56A6), phospho-ERK (#D13.14.4E), MMP1 (#E9S9N), and NF1 (#D7R7D)"
    whyMissed: "Specific antibody with clone number - clear research tool"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "anti-phospho-ERK antibody (#D13.14.4E)"
    toolType: "antibody"
    foundIn: "methods"
    contextSnippet: "Antibodies used in western blotting targeting β-actin (#13E5), MEK1/2, Akt, c-Raf, ERK, phospho-MEK1/2 (#41G9), phospho-Akt (#D9E), phospho-c-Raf (#56A6), phospho-ERK (#D13.14.4E), MMP1 (#E9S9N), and NF1 (#D7R7D)"
    whyMissed: "Specific antibody with clone number - clear research tool"
    confidence: 0.95
    shouldBeAdded: Yes

  - toolName: "CFX Connect System"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "The qPCR reactions were performed with the CFX Connect System (Bio-Rad Laboratories, Hercules, CA, USA) using TB Green Premix Ex Taq"
    whyMissed: "qPCR instrument system with analysis software capabilities"
    confidence: 0.8
    shouldBeAdded: Maybe

  - toolName: "ChemiDoc XRS"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Chemiluminescence was detected using ChemiDoc XRS (Bio-Rad) and densitometric analysis was performed"
    whyMissed: "Imaging system with analysis software for densitometry"
    confidence: 0.8
    shouldBeAdded: Maybe

  - toolName: "EVOS Cell Imaging Systems"
    toolType: "computational_tool"
    foundIn: "methods"
    contextSnippet: "Chambers were covered with cell-mounting medium containing DAPI (Santa Cruz) and images were taken with EVOS Cell Imaging Systems (Thermo Fisher Scientific)"
    whyMissed: "Cell imaging system with analysis capabilities"
    confidence: 0.8
    shouldBeAdded: Maybe

suggestedPatterns:
  - patternType: "naming_convention"
    pattern: "anti-[A-Z0-9-]+ antibody \\(#[A-Z0-9.]+\\)"
    toolType: "antibody"
    examples: ["anti-NF1 antibody (#D7R7D)", "anti-MMP1 antibody (#E9S9N)", "anti-β-actin antibody (#13E5)"]
    reasoning: "Pattern to capture antibodies with clone numbers in parentheses - very specific format used in this paper"

  - patternType: "naming_convention"
    pattern: "[A-Z0-9]+ siRNA \\(s[0-9]+\\)"
    toolType: "genetic_reagent"
    examples: ["NF1 siRNA (s221793)", "AHR siRNA (s1200)"]
    reasoning: "Pattern to capture siRNA reagents with Thermo Fisher catalog numbers starting with 's'"

  - patternType: "context_phrase"
    pattern: "primary [a-z]+ cells were isolated from"
    toolType: "cell_line"
    examples: ["primary dermal fibroblast cells were isolated from biopsied skin tissue"]
    reasoning: "Pattern to identify primary cell cultures established from patient/tissue samples"

  - patternType: "vendor_indicator"
    pattern: "System \\([A-Za-z-]+ Laboratories"
    toolType: "computational_tool"
    examples: ["CFX Connect System (Bio-Rad Laboratories", "ChemiDoc XRS (Bio-Rad)"]
    reasoning: "Pattern to capture instrument systems that often include analysis software components"

observations: []

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 11
  newPatternsCount: 4
  observationsExtracted: 0
  observationsByType: {}
  majorIssuesFound: |
    - No tools were initially mined despite this being a comprehensive lab research study
    - Multiple clear research tools present in Methods section were missed
    - Antibodies with specific clone numbers not detected
    - siRNA reagents with catalog numbers not captured
    - Primary cell cultures not identified as research tools
  recommendations: |
    This publication contains numerous research tools that were completely missed by initial mining.
    The Methods section clearly describes experimental procedures using specific antibodies, siRNA reagents,
    and primary cell cultures. All potentially missed tools should be added as they represent genuine
    research tools with specific identifiers and vendor information. The suggested patterns would help
    capture similar tools in future mining efforts. No observations were extracted since no tools
    were initially validated, but this study would likely contain valuable phenotypic observations
    about MMP1 regulation and drug effects once tools are properly identified.